Disruptor Profile: Pear Therapeutics, Inc.

Research By Markets adds Market Research Report - Disruptor Profile: Pear Therapeutics, Inc.

For detailed information: https://www.researchbymarkets.com/report/disruptor-profile-pear-therapeutics-inc-372793.html

Disruptor Profile: Pear Therapeutics, Inc.

Summary

The report provides information and insights into Pear Therapeutics, Inc.’s, including –
– Overview of the company and its product offering
– Detailed insight into its business model, company type and headquarter
– Information on partnership and funding
– Biography of top management.

Scope

– Pear Therapeutics Inc. (Pear) is a pioneer in software-based prescription digital therapeutics (PDT) for the treatment of severe diseases and serious medical conditions.

Reasons to buy

– Gain insights into Pears’s business operations.
– Gain insights into funding and partnerships
– Gain understanding about its technology focus.

Companies Mentioned:
Sandoz
Novartis
EDBI Pte Ltd
Blue Water Life Science Fund LP
Bridge Builders Collaborative
5AM Venture Management LLC
Novartis AG
TrustBridge Partners
Arboretum Ventures LLC
Temasek Holdings (Private) Ltd
JAZZ Venture Partners L.P.


For specific queries regarding this report: https://www.researchbymarkets.com/inquiry/372793

Contact Us:
ResearchByMarkets.com
Sales Desk
enquiry@researchbymarkets.com
USA: +1-800-416-3124
https://www.researchbymarkets.com/aboutus

Follow us on Social Media:
Facebook: https://www.facebook.com/researchbymarkets/
LinkedIn: https://www.linkedin.com/company/researchbymarkets/
Twitter: https://twitter.com/ResearchByMrkts

Market Research News brings the latest news and updates about the Industry.